Late onset vascular dysfunction in the R6/1 model of Huntington's disease

European Journal of Pharmacology

Volumn 698, Issue 1-3, 2013, Pages 345-353

  Rahman, Awahan ^a   Ekman, Mari ^a   Shakirova, Yulia ^a   Andersson, Kristina E ^a   Mörgelin, Matthias ^b   Erjefält, Jonas S ^a   Brundin, Patrik ^a   Li, Jia Yi ^a   Swärd, Karl ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Calcium waves; Huntington's disease; Mitochondria; R6 1; Vascular dysfunction

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYCLIC GMP DEPENDENT PROTEIN KINASE; MITOCHONDRIAL PROTEIN; MYOSIN LIGHT CHAIN; POTASSIUM CHANNEL; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUNTINGTON CHOREA; MALE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VASCULAR DISEASE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ARTERIES; CALCIUM SIGNALING; CYANIDES; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MICE; MITOCHONDRIA; MUSCLE CELLS; MYOGRAPHY; ROTENONE; TIME FACTORS; VASOCONSTRICTION;

EID: 84871921332     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.10.026     Document Type: Article

References (34)

1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group, 1993. Cell 72, 971-983
2. O.A. Andreassen, A. Dedeoglu, V. Stanojevic, D.B. Hughes, S.E. Browne, C.A. Leech, R.J. Ferrante, J.F. Habener, M.F. Beal, and M.K. Thomas Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression Neurobiol. Dis. 11 2002 410 424 (Pubitemid 36269126)
3. J. Arenas, Y. Campos, R. Ribacoba, M.A. Martín, J.C. Rubio, P. Ablanedo, and A. Cabello Complex I defect in muscle from patients with Huntington's disease Ann. Neurol. 43 1998 397 400 (Pubitemid 28113606)
4. N.A. Aziz, J.M.M. van der Burg, G.B. Landwehrmeyer, P. Brundin, T. Stijnen, and R.A.C. Roos Weight loss in Huntington disease increases with higher CAG repeat number Neurology 71 2008 1506 1513
5. A. Benchoua, Y. Trioulier, D. Zala, M.-C. Gaillard, N. Lefort, N. Dufour, F. Saudou, J.-M. Elalouf, E. Hirsch, P. Hantraye, N. Déglon, and E. Brouillet Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin Mol. Biol. Cell 17 2006 1652 1663 (Pubitemid 44011583)
6. M. Björkqvist, M. Fex, E. Renström, N. Wierup, A. Petersén, J. Gil, K. Bacos, N. Popovic, J.-Y. Li, F. Sundler, P. Brundin, and H. Mulder The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis Hum. Mol. Genet. 14 2005 565 574 (Pubitemid 40309582)
7. M. Björkqvist, A. Petersén, K. Bacos, J. Isaacs, P. Norlén, J. Gil, N. Popovic, F. Sundler, G.P. Bates, S.J. Tabrizi, P. Brundin, and H. Mulder Progressive alterations in the hypothalamic-pituitary- adrenal axis in the R6/2 transgenic mouse model of Huntington's disease Hum. Mol. Genet. 15 2006 1713 1721 (Pubitemid 43904837)
8. E. Brondum, H. Kold-Petersen, H. Nilsson, A. Flyvbjerg, and C. Aalkjaer Increased contractility to noradrenaline and normal endothelial function in mesenteric small arteries from the Goto-Kakizaki rat model of type 2 diabetes J. Physiol Sci. 58 2008 333 339
9. S.E. Browne Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models Ann. N.Y. Acad. Sci. 1147 2008 358 382
10. A. Caporali, and C. Emanueli Cardiovascular actions of neurotrophins Physiol. Rev. 89 2009 279 308
11. A.W. Deckel, and D. Cohen Increased CBF velocity during word fluency in Huntington's disease patients Prog. Neuro-Psychopharmacol. Biol. Psychiatry 24 2000 193 206 (Pubitemid 30159529)
12. A.W. Deckel, A. Gordinier, D. Nuttal, V. Tang, C. Kuwada, R. Freitas, and K.A. Gary Reduced activity and protein expression of NOS in R6/2 HD transgenic mice: effects of l-NAME on symptom progression Brain Res. 919 2001 70 81 (Pubitemid 33016591)
13. M. Félétou, R. Köhler, and P.M. Vanhoutte Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets Curr. Hypertens. Rep. 12 2010 267 275
14. P.S. Harper Huntington's disease 1996 W.B. Saunders London
15. J. Kobal, B. Meglic, A. Mesec, and B. Peterlin Early sympathetic hyperactivity in Huntington's disease Eur. J. Neurol. 11 2004 842 848 (Pubitemid 39665063)
16. D. Lambrechts, E. Storkebaum, M. Morimoto, J. Del-Favero, F. Desmet, S.L. Marklund, S. Wyns, V. Thijs, J. Andersson, I. van Marion, A. Al-Chalabi, S. Bornes, R. Musson, V. Hansen, L. Beckman, R. Adolfsson, H.S. Pall, H. Prats, S. Vermeire, P. Rutgeerts, S. Katayama, T. Awata, N. Leigh, L. Lang-Lazdunski, M. Dewerchin, C. Shaw, L. Moons, R. Vlietinck, K.E. Morrison, W. Robberecht, C. Van Broeckhoven, D. Collen, P.M. Andersen, and P. Carmeliet VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death Nat. Genet. 34 2003 383 394 (Pubitemid 36935331)
17. L. Mangiarini, K. Sathasivam, M. Seller, B. Cozens, A. Harper, C. Hetherington, M. Lawton, Y. Trottier, H. Lehrach, S.W. Davies, and G.P. Bates Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice Cell 87 1996 493 506 (Pubitemid 26374323)
18. M.J. Mihm, D.M. Amann, B.L. Schanbacher, R.A. Altschuld, J.A. Bauer, and K.R. Hoyt Cardiac dysfunction in the R6/2 mouse model of Huntington's disease Neurobiol. Dis. 25 2007 297 308 (Pubitemid 46127844)
19. M. Mita, T. Kuramoto, K. Ito, N. Toguchi-Senrui, S. Hishinuma, M.P. Walsh, and M. Shoji Impairment of α1-adrenoceptor-mediated contractile activity in caudal arterial smooth muscle from type 2 diabetic Goto-Kakizaki rats Clin. Exp. Pharmacol. Physiol. 37 2010 350 357
20. A.V. Panov, C.-A. Gutekunst, B.R. Leavitt, M.R. Hayden, J.R. Burke, W.J. Strittmatter, and J.T. Greenamyre Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines Nat. Neurosci. 5 2002 731 736 (Pubitemid 34827590)
21. J.S. Pattison, A. Sanbe, A. Maloyan, H. Osinska, R. Klevitsky, and J. Robbins Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure Circulation 117 2008 2743 2751 (Pubitemid 351770455)
22. J. Phan, M.A. Hickey, P. Zhang, M.-F. Chesselet, and K. Reue Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models Hum. Mol. Genet. 18 2009 1006 1016
23. A. Rahman, and K. Swärd The role of caveolin-1 in cardiovascular regulation Acta Physiol. (Oxf) 195 2009 231 245
24. P.H. Reddy, P. Mao, and M. Manczak Mitochondrial structural and functional dynamics in Huntington's disease Brain Res. Rev. 61 2009 33 48
25. I. Segura, F. De Smet, P.J. Hohensinner, C. Ruiz de Almodovar, and P. Carmeliet The neurovascular link in health and disease: an update Trends. Mol. Med. 15 2009 439 451
26. A.P. Somlyo, and A.V. Somlyo Signal transduction and regulation in smooth muscle Nature 372 1994 231 236 (Pubitemid 24352442)
27. T.V. Strong, D.A. Tagle, J.M. Valdes, L.W. Elmer, K. Boehm, M. Swaroop, K.W. Kaatz, F.S. Collins, and R.L. Albin Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues Nat. Genet. 5 1993 259 265 (Pubitemid 23330389)
28. K. Swärd, K. Dreja, A. Lindqvist, E. Persson, and P. Hellstrand Influence of mitochondrial inhibition on global and local [Ca(2+)](I) in rat tail artery Circ. Res. 90 2002 792 799 (Pubitemid 34633895)
29. S.J. Tabrizi, D.R. Langbehn, B.R. Leavitt, R.A. Roos, A. Durr, D. Craufurd, C. Kennard, S.L. Hicks, N.C. Fox, R.I. Scahill, B. Borowsky, A.J. Tobin, H.D. Rosas, H. Johnson, R. Reilmann, B. Landwehrmeyer, and J.C. Stout Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data Lancet Neurol. 8 2009 791 801
30. M.J. Taggart, and S. Wray Hypoxia and smooth muscle function: key regulatory events during metabolic stress J. Physiol. (Lond.) 509 Pt 2 1998 315 325 (Pubitemid 28286991)
31. E. Trushina, R.D. Singh, R.B. Dyer, S. Cao, V.H. Shah, R.G. Parton, R.E. Pagano, and C.T. McMurray Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo Hum. Mol. Genet. 15 2006 3578 3591 (Pubitemid 44884124)
32. J.M.M. van der Burg, K. Bacos, N.I. Wood, A. Lindqvist, N. Wierup, B. Woodman, J.I. Wamsteeker, R. Smith, T. Deierborg, M.J. Kuhar, G.P. Bates, H. Mulder, C. Erlanson-Albertsson, A.J. Morton, P. Brundin, A. Petersén, and M. Björkqvist Increased metabolism in the R6/2 mouse model of Huntington's disease Neurobiol. Dis. 29 2008 41 51 (Pubitemid 350180481)
33. J.M.M. van der Burg, M. Björkqvist, and P. Brundin Beyond the brain: widespread pathology in Huntington's disease Lancet Neurol. 8 2009 765 774
34. J.P. Vonsattel, R.H. Myers, T.J. Stevens, R.J. Ferrante, E.D. Bird, and E.P. Richardson Jr Neuropathological classification of Huntington's disease J. Neuropathol. Exp. Neurol. 44 1985 559 577 (Pubitemid 16196286)